Global Franchise Medical Head at ViiV Healthcare, responsible for medical strategy across our portfolio of HIV products. Previously Global Medical Lead for dolutegravir, where he played a pivotal role in ViiV’s 2-drug regimen strategy.
Prior to industry, he graduated MBChB, and subsequently specialised in Genito-urinary/HIV Medicine at Guys’ and St Thomas’ Hospitals in London. Michael is a Member of the Royal College of Physicians (MRCP) and holds
a Masters in Business Administration (MBA) from Imperial College London Business School.
